Prime Minister Moustafa Madbouli reaffirmed the government’s unwavering commitment to securing a sustainable and efficient supply of essential medical goods for all citizens, stressing that the settlement of arrears owed to suppliers of the Unified Procurement Authority (UPA) remains a top priority.
During a meeting held on Tuesday to review the UPA’s financial position and the latest developments in supplier payments, Madbouli underscored the importance of safeguarding the financial stability of partner companies and ensuring the uninterrupted flow of medical supply chains. He stressed that addressing the Authority’s financial challenges is critical to maintaining consistent service delivery across state-run hospitals.
The prime minister further highlighted that honoring contractual obligations is key to fostering a competitive and attractive investment climate for both local and international manufacturers of pharmaceuticals and medical equipment.
The meeting was attended by Minister of Planning and Economic Development Ahmed Rostom, Presidential Advisor for Financial Affairs Ahmed El-Shazly, UPA Chairman Hisham Stait, along with senior officials from the Ministries of Finance and Health.
Discussions during the meeting covered a comprehensive review of the UPA’s debt profile and budgetary allocations, with a focus on securing the necessary liquidity to meet supplier dues in line with agreed timelines. The prime minister added that coordination is ongoing between the UPA and the Ministries of Finance and Planning to accelerate the collection of outstanding receivables from various state entities.
The meeting also reviewed recent upgrades to the “MedIQ” digital platform, which marks a significant advancement in procurement governance through integrated financial systems that enable precise tracking and real-time auditing of supplier entitlements.
Concluding the meeting, Madbouli directed officials to intensify efforts to implement a comprehensive settlement plan, noting that these steps send a strong message of reassurance to both local and international investors. He affirmed that the state remains committed to maintaining a stable business environment that supports the growth of the pharmaceutical sector and advances the localisation of modern medical technologies in Egypt.
